Drug Development and Industrial Pharmacy · 1985 · 19 citations · 6 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDissolution TestingPharmaceutical FormulationDissolution MediaDrug DissolutionDrug SolubilityFormulation Effects On BioavailabilityFormulation Effects On DissolutionSolubility EnhancementDispersionsDissolution Of Solid DispersionsDissolution Rate AnalysisDissolution Rate DeterminationDissolution ReactionsDrug Dissolution KineticsOral Solid Dosage Form DissolutionSolid Dispersion Formulation
AbstractThe dissolution of carbamazepine and nitrazepam from Its solid dispersions using anhydrous lactose, mannitol, galactose, PEG 6000 and coprecipitate using polyvinylpyrrolidone (PVP) 40,000 was investigated. The dissolution process of capsules containing either carbamazepine or nitrazepam as solid dispersion or coprecipitate followed an apparent first order process. The combination of carbamazepine with sugars (mannitol, lactose, and galactose) caused, in every case, an increase in the dissolution rate of the drug. Carbamazepine-PVP coprecipitate gave the higher dissolution rate than that of the solid dispersions with sugars and PEG 6000. Nitrazepam-lactose system gave higher dissolution rate than the other dispersions and coprecipitate. This enhancement in dissolution rate was much more obvious for the solid dispersions and coprecipitate than for the physical mixtures.
6
Clinical Pharmacokinetics of Carbamazepine
Clinical Pharmacokinetics · 1978 · 228 citations
[Clinical pharmacokinetics of carbamazepine].
R Kanarkowski, Janusz Rybakowski · PubMed · 1990 · 195 citations
Pharmacokinetics of carbamazepine in normal man
René H. Levy, William H. Pitlick, Allan S. Troupin et al. · Clinical Pharmacology & Therapeutics · 1975 · 139 citations